Symptoms and Daily Manifestations
At a Glance
GLS gain-of-function and MSMO1 deficiency can cause eye and developmental problems in children. Seizures are linked to GLS variants, while psoriasis-like skin changes are more typical of MSMO1 deficiency; symptoms alone cannot confirm the diagnosis, so metabolic testing is needed.
When a child is born with an ultra-rare symptom cluster, the way those symptoms show up in daily life can be confusing. For conditions like GLS gain-of-function or MSMO1 deficiency, four core features are often evaluated in the early years: cataracts, skin changes, developmental delay, and neurological symptoms like seizures [1][2].
Because these conditions are so rare, severity and the presence of individual features vary widely. The table and features below cannot definitively identify the diagnosis without metabolic testing.
URGENT: Red Flags Requiring Immediate Care
- Leukocoria (White Pupil): If you see a “white or grey glow” in the pupil, get a prompt or urgent pediatric ophthalmology assessment. While this can be a cataract, it is also a sign of retinoblastoma and other serious retinal diseases that must be excluded immediately.
- Seizure Emergencies: Call emergency services for a first seizure, a seizure lasting more than five minutes, any breathing or color change during an event, or a rapid loss of previously acquired skills.
The Eyes: Infantile and Congenital Cataracts
The most visible sign is often a clouding of the lens in one or both eyes.
- Timing: In MSMO1 deficiency, these are frequently congenital, meaning they are present at the moment of birth [2]. In GLS variants, they are often described as infantile, appearing within the first few months of life [1].
- What to watch for: You may notice a white or grey glow in your child’s pupil (the dark center of the eye) or notice that they do not seem to track your face or bright toys [3].
- Mimics: While cataracts can be part of these metabolic clusters, they are sometimes mistaken for isolated eye issues or other genetic syndromes like Vici syndrome, which also involves heart and immune system problems [4][5].
The Skin: Psoriasiform Dermatitis and Ichthyosis
Skin abnormalities are a hallmark of MSMO1 deficiency but are rarely seen in GLS variants [6].
- Psoriasiform Dermatitis: This looks like red, scaly, and thickened patches of skin that can resemble psoriasis. These patches often appear in infancy [2][6].
- Ichthyosis and Scalp Issues: Some children may have more generalized dry, “fish-scale” skin (ichthyosis) or severe, stubborn scalp dandruff [2][7].
- Mimics: These skin signs are frequently misdiagnosed as common eczema or cradle cap before the full metabolic picture is understood [7].
The Brain: Developmental Delay and Intellectual Disability
Both conditions can affect how a child’s brain develops, but the severity varies widely.
- GLS Variants: These are often associated with profound developmental delay, meaning the child may take much longer to reach milestones like sitting, crawling, or communicating [1].
- MSMO1 Deficiency: This can range from severe intellectual disability to milder learning and behavioral challenges that become more apparent as the child reaches school age [2][7].
- Growth: Many children with these clusters also experience growth delay, appearing smaller or shorter than expected for their age [2].
Neurological Symptoms: Seizures and Tone
The “chemical stress” in the brain—whether from too much glutamate or too little cholesterol—can cause the brain’s electrical system to misfire.
- Seizures: In reported children with GLS variants, epilepsy is common. These might look like classic tonic-clonic seizures (stiffening and jerking) or more subtle “staring spells” [8][9].
- Muscle Tone: Some children may have spasticity (stiff, tight muscles) or motor delay, making it difficult for them to coordinate their movements [7][6].
- Regression: While most of these conditions cause a delay in gaining skills, it is important to watch for regression, where a child suddenly loses a skill they already had. This should be reported to a neurologist immediately [1].
| Symptom | What it looks like | Which condition? |
|---|---|---|
| Cataracts | Clouding of the eye’s lens | Reported in both [1][3] |
| Dermatitis | Red, scaly, “psoriasis-like” patches | Primary feature of MSMO1 [2] |
| Seizures | Staring spells or rhythmic jerking | Reported in GLS [9] |
| Developmental Delay | Difficulty learning and communicating | Found in both, severity varies [1][7] |
Common questions in this guide
What symptoms can GLS gain-of-function or MSMO1 deficiency cause in a child?
How can I tell whether my baby has a congenital or infantile cataract?
Is a white pupil in a baby an emergency?
What skin changes suggest MSMO1 deficiency?
When should a seizure or loss of skills be treated as urgent?
Can symptoms alone distinguish GLS gain-of-function from MSMO1 deficiency?
What should I record before my child's specialist visit?
Get notified when new evidence is published on infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (9)
- 1
GLS hyperactivity causes glutamate excess, infantile cataract and profound developmental delay.
Rumping L, Tessadori F, Pouwels PJW, et al.
Human molecular genetics 2019; (28(1)):96-104 doi:10.1093/hmg/ddy330.
PMID: 30239721 - 2
A rare case of sterol-C4-methyl oxidase deficiency in a young Italian male: Biochemical and molecular characterization.
Frisso G, Gelzo M, Procopio E, et al.
Molecular genetics and metabolism 2017; (121(4)):329-335 doi:10.1016/j.ymgme.2017.06.013.
PMID: 28673550 - 3
Infantile Cataracts Associated with a Homozygous Missense MSMO1 Variant-Case Report and Literature Review.
Hassas N, Drackley A, Ivanisevic J, et al.
Reports (MDPI) 2026; (9(1)) doi:10.3390/reports9010045.
PMID: 41718295 - 4
Defects in autophagosome-lysosome fusion underlie Vici syndrome, a neurodevelopmental disorder with multisystem involvement.
Hori I, Otomo T, Nakashima M, et al.
Scientific reports 2017; (7(1)):3552 doi:10.1038/s41598-017-02840-8.
PMID: 28615637 - 5
EPG5-Related Disorders in Seven New Patients: Refining the Phenotypic Spectrum and Insights on Phenotype-Genotype Correlations.
Abdel-Ghafar SF, Ahmed AE, Mohammed ET, et al.
Journal of molecular neuroscience : MN 2025; (75(4)):147 doi:10.1007/s12031-025-02419-3.
PMID: 41184612 - 6
New Homozygous Missense MSMO1 Mutation in Two Siblings with SC4MOL Deficiency Presenting with Psoriasiform Dermatitis.
Kalay Yildizhan I, Gökpınar İli E, Onoufriadis A, et al.
Cytogenetic and genome research 2020; (160(9)):523-530 doi:10.1159/000511126.
PMID: 33161406 - 7
MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly.
Tkemaladze T, Bratland E, Bregvadze K, et al.
Clinical dysmorphology 2023; (32(3)):97-105 doi:10.1097/MCD.0000000000000461.
PMID: 37195326 - 8
A second case of glutaminase hyperactivity: Expanding the phenotype with epilepsy.
Rumping L, Pouwels PJW, Wolf NI, et al.
JIMD reports 2023; (64(3)):217-222 doi:10.1002/jmd2.12359.
PMID: 37151363 - 9
Structure and enzymology of glutaminase S482C and H461L variants associated with excess brain glutamate and neurological disease.
Crane CS, McIssac TK, Milano SK, et al.
The Journal of biological chemistry 2026; (302(6)):113091 doi:10.1016/j.jbc.2026.113091.
PMID: 42055345
This page is for informational purposes only and does not constitute medical advice about your child's symptoms. A pediatric ophthalmologist, neurologist, dermatologist, or metabolic specialist should evaluate concerning findings, especially a white pupil, seizures, or loss of skills.